Patents Assigned to Japan as Represented by Director General of Agency of National Institute of Infectious Diseases
  • Remedies for hepatitis C
    Patent number: 7101551
    Abstract: The present invention provides a substance which inhibits the binding between E2/NS1 protein of hepatitis C virus and a cell infectious with hepatitis C virus, a cell expressing CD81, or CD81. The present invention can provide a novel medicament which has an anti-viral effects such as an inhibitory action against HCV infection.
    Type: Grant
    Filed: February 13, 2001
    Date of Patent: September 5, 2006
    Assignees: Mitsubishi Pharma Corporation, Japan as Represented by Director General of Agency of National Institute of Infectious Diseases
    Inventors: Seima Itami, Tatsurou Shibui, Makoto Seki, Yoshihisa Yotsumoto, Yoshiharu Matsuura, Tatsuo Miyamura